Search research articles
Contact Us
Filters
Showing results (151-160 of 162) with videos related to
Page
of 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2025
Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma
Sundar Jagannath, Thomas G Martin, Yi Lin, et al.
Nature Medicine
|
August 26, 2020
An inflammatory cytokine signature predicts COVID-19 severity and survival
Diane Marie Del Valle, Seunghee Kim-Schulze, Hsin-Hui Huang, et al.
Journal for Immunotherapy of Cancer
|
December 30, 2025
Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignancies
Adila Izgutdina, Tasfia Rashid, William C Temple, et al.
The New England Journal of Medicine
|
August 20, 2025
Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy
Adolfo Aleman, Oliver Van Oekelen, David T Melnekoff, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2025
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell Malignancies
Adila Izgutdina, Tasfia Rashid, William C Temple, et al.
Haematologica
|
April 1, 2021
Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma
Man Chun John Ma, Saber Tadros, Alyssa Bouska, et al.
Cancer Discovery
|
March 17, 2025
PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting
Mansi Saxena, Thomas U Marron, Julia Kodysh, et al.
Blood
|
May 13, 2025
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells
Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2025
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
Hervé Avet-Loiseau, Faith E Davies, Mehmet K Samur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 25, 2025
Erratum: International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
Hervé Avet-Loiseau, Faith E Davies, Mehmet K Samur, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 162) with videos related to
Sort By:
Page
of 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2025
Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma
Sundar Jagannath, Thomas G Martin, Yi Lin, et al.
Nature Medicine
|
August 26, 2020
An inflammatory cytokine signature predicts COVID-19 severity and survival
Diane Marie Del Valle, Seunghee Kim-Schulze, Hsin-Hui Huang, et al.
Journal for Immunotherapy of Cancer
|
December 30, 2025
Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignancies
Adila Izgutdina, Tasfia Rashid, William C Temple, et al.
The New England Journal of Medicine
|
August 20, 2025
Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy
Adolfo Aleman, Oliver Van Oekelen, David T Melnekoff, et al.
Biorxiv : the Preprint Server for Biology
|
June 4, 2025
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell Malignancies
Adila Izgutdina, Tasfia Rashid, William C Temple, et al.
Haematologica
|
April 1, 2021
Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma
Man Chun John Ma, Saber Tadros, Alyssa Bouska, et al.
Cancer Discovery
|
March 17, 2025
PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting
Mansi Saxena, Thomas U Marron, Julia Kodysh, et al.
Blood
|
May 13, 2025
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells
Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2025
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
Hervé Avet-Loiseau, Faith E Davies, Mehmet K Samur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 25, 2025
Erratum: International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
Hervé Avet-Loiseau, Faith E Davies, Mehmet K Samur, et al.
Page
of 17